Kaiwu Capital, LLC (Beijing, China)
Karen Liu has been an active VC investor in China healthcare related sectors in the past 5-6 years, with investment experiences in medical device, drug, diagnostic, service and industrial biotech. Prior to joining Kaiwu, Karen was a Managing Director at CRCI Capital and was responsible for investing in 6 healthcare and life science related companies. Karen was also an early co-founder and angel investor for Shenogen Pharma, an innovative drug discovery and development company developing therapeutics targeting cancer stem cells. From 2000-2004, Karen was an Internet entrepreneur. As a key senior management member at 3721.com, she helped build up the small Internet company to become one of the leading Internet names in China until it was sold to Yahoo in 2004. Karen Liu had worked as a management consultant at McKinsey and & Company Beijing office.
Karen received her PhD degree in the field of Immunology and Master of Medical Sciences from Harvard Medical School. She also has a Bachelor of Sciences degree from Cornell University and an EMBA degree from the Chung Kong Graduate School of Business in Beijing.